Equalum Secures $14M in Series C Funding to Expand Delivery of Continuous Data Integration
Funding to Accelerate Growth, Innovation, and Expansion into New Markets
Source: einnews.com
Page 3 - David Marek News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Marek. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Marek Today - Breaking & Trending Today
Myovant Sciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
BASEL, Switzerland, June 03, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science, empowering medicines,
Source: djournal.com
Government Reconvenes National Economic Council
At a meeting on Wednesday, 18 May, Petr Fiala's government decided to reconvene the government's National Economic Council, approving new statutes and members for the body. The National Economic Council will have 19 members, all renowned economists, and its coordinator will be Jan Procházka, Chairma
Source: brnodaily.com
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer | Proteins and Peptides
Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer
Source: pipelinereview.com